SecSonar.com

Caribou Biosciences, Inc. (CRBU)

Caribou Biosciences, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Caribou Biosciences, Inc. (CRBU) is a Biotechnology company based in US with a market capitalization of $235.6M. Revenue grew 11.7% year-over-year and free cash flow was negative at -$112.4M. This page tracks CRBU's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 147 employees · IPO Jul 23, 2021

Valuation

Valuation & price

$2.14 · as of May 17, 2026 · -24.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.93

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.84$2.11$1.39Jul 25Dec 25Jul 26Jul 7, 25$1.39Jul 9, 25$1.75Jul 11, 25$1.63Jul 15, 25$1.61Jul 17, 25$1.83Jul 21, 25$2.07Jul 23, 25$2.48Jul 25, 25$2.28Jul 29, 25$1.96Jul 31, 25$2.03Aug 4, 25$2.10Aug 6, 25$1.88Aug 11, 25$1.71Aug 13, 25$1.95Aug 15, 25$1.98Aug 19, 25$1.77Aug 21, 25$1.84Aug 25, 25$1.88Aug 27, 25$1.98Aug 29, 25$1.87Sep 3, 25$1.89Sep 5, 25$1.87Sep 9, 25$1.84Sep 11, 25$1.91Sep 16, 25$1.80Sep 18, 25$1.78Sep 22, 25$1.93Sep 24, 25$2.13Sep 26, 25$2.13Sep 30, 25$2.33Oct 2, 25$2.23Oct 6, 25$2.34Oct 8, 25$2.68Oct 10, 25$2.49Oct 14, 25$2.44Oct 16, 25$2.67Oct 21, 25$2.84Oct 23, 25$2.50Oct 27, 25$2.45Oct 29, 25$2.37Oct 31, 25$2.42Nov 4, 25$2.17Nov 6, 25$2.14Nov 10, 25$2.07Nov 12, 25$2.26Nov 14, 25$1.99Nov 18, 25$1.87Nov 20, 25$1.75Nov 25, 25$1.87Nov 28, 25$1.94Dec 2, 25$1.76Dec 4, 25$1.94Dec 8, 25$1.89Dec 10, 25$1.90Dec 12, 25$1.79Dec 16, 25$1.69Dec 18, 25$1.63Dec 22, 25$1.72Dec 24, 25$1.72Dec 29, 25$1.65Jan 2, 26$1.59Jan 6, 26$1.72Jan 8, 26$1.69Jan 12, 26$1.58Jan 14, 26$1.61Jan 16, 26$1.46Jan 21, 26$1.49Jan 23, 26$1.53Jan 27, 26$1.55Jan 29, 26$1.48Feb 2, 26$1.46Feb 4, 26$1.62Feb 9, 26$1.63Feb 11, 26$1.59Feb 13, 26$1.58Feb 18, 26$1.62Feb 20, 26$1.80Feb 24, 26$2.14Feb 26, 26$1.99Mar 2, 26$1.84Mar 4, 26$1.80Mar 6, 26$1.82Mar 10, 26$2.03Mar 12, 26$1.89Mar 17, 26$1.97Mar 19, 26$1.97Mar 23, 26$1.86Mar 25, 26$1.88Mar 27, 26$1.78Mar 31, 26$1.90Apr 2, 26$1.94Apr 7, 26$1.86Apr 9, 26$1.96Apr 13, 26$1.95Apr 15, 26$2.20Apr 17, 26$2.20Apr 22, 26$2.36Apr 24, 26$2.13Apr 28, 26$2.08Apr 30, 26$1.88May 4, 26$1.91May 6, 26$1.95May 8, 26$1.94May 12, 26$2.03May 14, 26$2.14May 18, 26$2.07May 20, 26$2.00May 22, 26$2.10May 28, 26$2.31Jun 1, 26$2.43Jun 3, 26$2.00Jun 5, 26$1.92Jun 9, 26$1.84Jun 11, 26$1.66Jun 15, 26$1.66Jun 17, 26$1.64Jun 22, 26$1.64Jun 24, 26$1.66Jun 26, 26$1.68Jul 2, 26$1.82
$1.3952-week range$2.84
Loading valuation history…

Fundamentals

Key fundamentals

$235.6M

Market cap

11.7%

Revenue growth (YoY)

67.3%

Gross margin

-$112.4M

Free cash flow (USD)

-$112.1M

Net debt

Net cash position

3.4%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$5.8MFY 2020$12.4MFY 2021$9.6MFY 2022$13.9MFY 2023$34.5MFY 2024$10.0MFY 2025$11.2M
$5.8M$11.2M

Free cash flow by year

2019 → 2025

FY 2019$-32.9MFY 2020$-34.5MFY 2021$-35.6MFY 2022$-97.4MFY 2023$-104.9MFY 2024$-144.7MFY 2025$-112.4M
-$32.9M-$112.4M

Gross margin by year

2021 → 2025

FY 202189.8%FY 202273.7%FY 202389.8%FY 202460.7%FY 202567.3%
89.8%67.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 18, 2026Filing
  • 8-K eventClinical Trial Data AnnouncedJun 11, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing
  • 8-K eventRegulatory Designation ReceivedMar 31, 2026Filing

Questions

Frequently asked questions

What is Caribou Biosciences, Inc.'s market cap?

Caribou Biosciences, Inc. (CRBU) has a market capitalization of $235.6M.

What is CRBU's P/E ratio?

A meaningful P/E ratio is not available for CRBU — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is CRBU's price-to-book (P/B) ratio?

CRBU trades at 1.93 times book value per share.

Are insiders buying CRBU stock?

SEC Form 4 filings show no open-market insider buys at Caribou Biosciences, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

QSI

Quantum-Si incorporated

$235.4M

VYGR

Voyager Therapeutics, Inc.

$235.3M

SGMT

Sagimet Biosciences Inc.

$235M

OBIO

Orchestra BioMed Holdings, Inc.

$236.8M

WHWK

Whitehawk Therapeutics Inc

$232.4M

ALEC

Alector, Inc.

$242.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.